Cancer

MHRA approves trofolastat for prostate cancer imaging

In a world first, the Medicines and Healthcare Products Regulatory Agency (MHRA) has approved trofolastat to detect cancerous lesions in men with prostate cancer.

New drugs could stop ovarian cancer

Researchers at The University of Manchester have shown that a new class of drugs are able to stop ovarian cancer cells growing.

Insights into the mechanisms of primary brain tumour invasion

Thomas Daubon, Clotilde Billottet and Andreas Bikfalvi at the Angiogenesis and Tumor Microenvironment-INSERM U1029, Université Bordeaux provide insights into the mechanisms of primary brain tumour invasion.

Genetic link to leukaemia in children with Down’s syndrome

Researchers at the University of Oxford have found that there is a gene link to leukaemia, already present in children with Down's syndrome.

Tackling sepsis through hand hygiene

Chris Wakefield, Vice President, European Marketing & Product Development, at GOJO Industries-Europe Ltd explores hand hygiene and how infection prevention measures can be strengthened to help save lives.

Research reveals masterswitch in body’s immune system

Scientists have discovered a critical masterswitch in the body’s immune system with potentially major implications for the treatment of some of the most devastating diseases affecting humans.

The challenges of living with a diagnosis of Cancer and Dementia

For this year’s World Cancer Day, we spoke to Admiral Nurse, Debby Veigas, around the challenges that caring for someone with dementia and cancer brings.

Parents call for teachers to teach children about the signs and symptoms of cancer

Two-thirds of parents think teachers should teach school children about the signs and symptoms of cancer, it has emerged

Spotlight on tea’s top healthy ingredients

Tea is the nation’s favourite drink and for good reason: it not only tastes great, but it’s good for our wellbeing as it is full of healthy ingredients.

A trans-disciplinary approach to cancer research

The use of a trans-disciplinary approach to cancer research is necessary for complex systems like tumors.

ChiLTERN: European project to improve outcome of children with liver cancer

In this analysis, Professor Keith Wheatley tells us about The ChiLTERN project, the most comprehensive research study ever undertaken in children’s liver cancer

Point-of-care devices technology for therapeutic drug monitoring in cancer treatment and beyond

Christian Siebel and Dott.ssa Bianca Posocco detail the work of DIACHEMO, a Euroepan project developing a platform technology for point-of-care devices for chemotherapeutics and other drugs.

Bowel cancer – time to test at an earlier age

Your toilet habits can help determine what is going on inside your body and with Brits spending the equivalent of eight months of their adult life sat on the toilet, it is time to test for bowel cancer at an earlier age

Biomarkers and patients’ access to personalised oncology drugs in Europe

Heinz Zwierzina M.D., CDDF Managing Director tells us all about biomarkers and patients’ access to personalised oncology drugs in Europe in this insightful article

Call for free dental care for mouth cancer patients to put an end to discriminatory ‘tax on cancer’

The Oral Health Foundation is calling for free dental care for mouth cancer patients to combat the discriminatory costs of ongoing healthcare that survivors are often burdened with

Mouth Cancer Action Month: What causes mouth cancer?

Dr. Harold Katz, dentist, bacteriologist and developer of The Breath Company discusses what are the main causes of mouth cancer in aid of Mouth Cancer Action Month

Functional metagenomics: Keys to modern biotechnology and new drugs

Professor Wolfgang Streit from the University of Hamburg details how functional metagenomics applies to modern biotechnology, new drugs and much more.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders